CLNO, GMT, GWR, DF Stock Market Update from CRWEPicks.com
NYMX, NHPR, CLNO, GWR, TRH, TEL - PennyToBuck.com Stock Report!
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) specializes in the research and development of novel drugs and diagnostic products for the aging population. Nymox Pharmaceutical’s lead drug candidate is NX-1207, a proprietary treatment for enlarged prostate or benign prostatic hyperplasia (BPH). NX-1207 is currently in Phase 3 trials in the United States.